CorMedix Inc. (NASDAQ:CRMD): When Will It Breakeven? [Yahoo! Finance]
CorMedix Inc. (CRMD)
NASDAQ:AMEX Investor Relations:
cormedix.com
Company Research
Source: Yahoo! Finance
CorMedix Inc. ( NASDAQ:CRMD is possibly approaching a major achievement in its business, so we would like to shine some light on the company. CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. The company's loss has recently broadened since it announced a US$46m loss in the full financial year, compared to the latest trailing-twelve-month loss of US$53m, moving it further away from breakeven. As path to profitability is the topic on CorMedix's investors mind, we've decided to gauge market sentiment. We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate. According to the 4 industry analysts covering CorMedix, the consensus is that breakeven is near. They expect the company to post a final loss in 2024, before turning a profit of US$9.9m in 2025. So, the c
Show less
Read more
Impact Snapshot
Event Time:
CRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRMD alerts
High impacting CorMedix Inc. news events
Weekly update
A roundup of the hottest topics
CRMD
News
- CorMedix (CRMD) Upgraded to Strong Buy: What Does It Mean for the Stock? [Yahoo! Finance]Yahoo! Finance
- CorMedix Inc. to Participate in the Truist Securities BioPharma SymposiumGlobeNewswire
- Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic [Yahoo! Finance]Yahoo! Finance
- CorMedix Inc. (NASDAQ: CRMD) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate [Yahoo! Finance]Yahoo! Finance
CRMD
Earnings
- 10/30/24 - Beat
CRMD
Sec Filings
- 11/18/24 - Form 4
- 11/14/24 - Form 144
- 11/14/24 - Form SC
- CRMD's page on the SEC website